Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

G. Comi, P. O'Connor, X. Montalban, J. Antel, E-W Radue, G. Karlsson, H. Pohlmann, S. Aradhye, L. Kappos

Research output: Contribution to journalArticleResearchpeer-review

142 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science